Leonid Aleksandrovich Laberko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Leonid Aleksandrovich Laberko has a total of 84 co-authors. Here are the top co-authors by number of shared publications:
- Kirill Victorovich Lobastov
Pirogov Russian National Research Medical University
19 shared publications - Ilya Veniaminovich Schastlivtsev
Pirogov Russian National Research Medical University
9 shared publications - Olga Yaroslavna Porembskaya
North-Western State Medical University Named After I.I. Mechnikov
8 shared publications - Sergey Anatolievich Sayganov
North-Western State Medical University named after I. I. Mechnikov
7 shared publications - Viacheslav Nikolaevich Kravchuk
North-Western State Medical University named after I.I. Mechnikov; Kirov Military Medical Academy
6 shared publications - Sergey Nikolaevich Tsaplin
Pirogov Russian National Research Medical University
5 shared publications
Latest Publications
- 22 September 2026
- Published by Media Sphere Publishing Group in Journal of Venous Disorders
- Vol. 20 (3)
Opportunities and Limitations of Artificial Intelligence in Phlebology: a Systematic Review with Meta-Analysis
Objective. To quantitatively evaluate the effectiveness of artificial intelligence (AI)-based technologies in diseases of the venous system. Material and methods. A systematic literature search was performed across the PubMed, Cochrane Library, and Google Scholar databases. Original studies utilizing AI models in venous pathology, including venous thromboembolism (VTE) and chronic venous disease (CVD), were included in the analysis. Study endpoints were the diagnostic and prognostic performance metrics, pooled using a random-effects model. Results. Of the 606 evaluated publications, 100 studies were included in the analysis addressing prediction (n=76) and diagnosis (n=24) of VTE (n=86) and CVD (n=14). For diagnostic models of VTE and CVD, the pooled accuracy, sensitivity, and specificity at internal validation were: 0.93 (95% CI: 0.87—0.96) and 0.98 (95% CI: 0.91—0.99); 0.89 (95% CI: 0.81—0.96) and 0.89 (95% CI: 0.80—0.95); 0.93 (95% CI: 0.87—0.98) and 0.94 (95% CI: 0.67—0.99), respectively. For predictive models of VTE, the pooled accuracy, sensitivity, specificity, precision, and AUC-ROC at internal validation were: 0.85 (95% CI: 0.83—0.88), 0.78 (95% CI: 0.72—0.85), 0.86 (95% CI: 0.80—0.92), 0.60 (95% CI: 0.45—0.74), and 0.86 (95% CI: 0.84—0.88), respectively. For predictive models of CVD, the pooled AUC was 0.88 (95% CI: 0.82—0.95). External validation was performed in only 23% of cases, and the obtained metrics were inferior to internal validation results. Conclusion. AI-based technologies demonstrate high diagnostic and moderate predictive performance in pathology of the venous system. However, further studies with external validation are required to assess implementation into clinical practice.
- 22 September 2026
- Published by Media Sphere Publishing Group in Journal of Venous Disorders
- Vol. 20 (3)
Opportunities and Limitations of Artificial Intelligence in Phlebology: a Systematic Review with Meta-Analysis
Objective. To quantitatively evaluate the effectiveness of artificial intelligence (AI)-based technologies in diseases of the venous system. Material and methods. A systematic literature search was performed across the PubMed, Cochrane Library, and Google Scholar databases. Original studies utilizing AI models in venous pathology, including venous thromboembolism (VTE) and chronic venous disease (CVD), were included in the analysis. Study endpoints were the diagnostic and prognostic performance metrics, pooled using a random-effects model. Results. Of the 606 evaluated publications, 100 studies were included in the analysis addressing prediction (n=76) and diagnosis (n=24) of VTE (n=86) and CVD (n=14). For diagnostic models of VTE and CVD, the pooled accuracy, sensitivity, and specificity at internal validation were: 0.93 (95% CI: 0.87—0.96) and 0.98 (95% CI: 0.91—0.99); 0.89 (95% CI: 0.81—0.96) and 0.89 (95% CI: 0.80—0.95); 0.93 (95% CI: 0.87—0.98) and 0.94 (95% CI: 0.67—0.99), respectively. For predictive models of VTE, the pooled accuracy, sensitivity, specificity, precision, and AUC-ROC at internal validation were: 0.85 (95% CI: 0.83—0.88), 0.78 (95% CI: 0.72—0.85), 0.86 (95% CI: 0.80—0.92), 0.60 (95% CI: 0.45—0.74), and 0.86 (95% CI: 0.84—0.88), respectively. For predictive models of CVD, the pooled AUC was 0.88 (95% CI: 0.82—0.95). External validation was performed in only 23% of cases, and the obtained metrics were inferior to internal validation results. Conclusion. AI-based technologies demonstrate high diagnostic and moderate predictive performance in pathology of the venous system. However, further studies with external validation are required to assess implementation into clinical practice.
- Open Access
- 21 November 2024
- Published by Remedium, Ltd. in Ambulatornaya khirurgiya = Ambulatory Surgery (Russia)
- Vol. 21 (2) , 244-257
An updated approach to the risk assessment and prevention of postoperative venous thromboembolism in varicose vein surgery
This narrative literature review is dedicated to the issue of individual risk assessment and prevention of postoperative VTE in patients undergoing lower limb varicose vein surgery. The registry-based CAPSIVS trial showed that the detection frequency of any forms of VTE after modern minimally invasive superficial vein surgery reaches 3.4%, of which only 0.5% are symptomatic. The current clinical guidelines regulate the individual risk assessment of postoperative thrombosis using the Caprini Risk Score (CRS). The first validation study resulted in a proposal of evidence-based approach to the phlebological patient stratification into risk groups according to the Caprini scores with 0–6 scores indicating the low risk, 7–10 scores – the moderate risk and 11 scores or more –the high risk, which differs significantly from approaches in other medical specialties. At the same time, the pharmacoprophylaxis may be appropriate in the groups of moderate and high risk, especially when simultaneous varicose tributary ablation and perforating vein interventions increasing the risk of VTEC 6–11 times are performed. The duration of pharmacoprophylaxis of postoperative venous thrombosis is essential to its efficiency, which should not be less than 7 days for the moderate VTE risk group and reach 30 days for the high VTE risk group. A single injection of parenteral anticoagulants on the day of surgery has been shown to be associated with an 8.8% incidence of postoperative thrombosis. The risk of postoperative thrombosis in patients with VTE in their past medical history, including prior varicothrombophlebitis is increased by 4.2 times, which requires that secondary pharmacoprophylaxis be prescribed for at least 30 days, and in some cases up to 3-6 months. At this stage, there is sufficient evidence to support the use of the Caprini Risk Score to assess the risk of postoperative VTE and prescribe adequate pharmacological prophylaxis in varicose vein surgery treatment.
- 21 November 2024
- Published by Remedium, Ltd. in Ambulatornaya khirurgiya = Ambulatory Surgery (Russia)
- Vol. 21 (2) , 244-257
Open AccessAn updated approach to the risk assessment and prevention of postoperative venous thromboembolism in varicose vein surgery
This narrative literature review is dedicated to the issue of individual risk assessment and prevention of postoperative VTE in patients undergoing lower limb varicose vein surgery. The registry-based CAPSIVS trial showed that the detection frequency of any forms of VTE after modern minimally invasive superficial vein surgery reaches 3.4%, of which only 0.5% are symptomatic. The current clinical guidelines regulate the individual risk assessment of postoperative thrombosis using the Caprini Risk Score (CRS). The first validation study resulted in a proposal of evidence-based approach to the phlebological patient stratification into risk groups according to the Caprini scores with 0–6 scores indicating the low risk, 7–10 scores – the moderate risk and 11 scores or more –the high risk, which differs significantly from approaches in other medical specialties. At the same time, the pharmacoprophylaxis may be appropriate in the groups of moderate and high risk, especially when simultaneous varicose tributary ablation and perforating vein interventions increasing the risk of VTEC 6–11 times are performed. The duration of pharmacoprophylaxis of postoperative venous thrombosis is essential to its efficiency, which should not be less than 7 days for the moderate VTE risk group and reach 30 days for the high VTE risk group. A single injection of parenteral anticoagulants on the day of surgery has been shown to be associated with an 8.8% incidence of postoperative thrombosis. The risk of postoperative thrombosis in patients with VTE in their past medical history, including prior varicothrombophlebitis is increased by 4.2 times, which requires that secondary pharmacoprophylaxis be prescribed for at least 30 days, and in some cases up to 3-6 months. At this stage, there is sufficient evidence to support the use of the Caprini Risk Score to assess the risk of postoperative VTE and prescribe adequate pharmacological prophylaxis in varicose vein surgery treatment.
- 13 September 2024
- Published by Media Sphere Publishing Group in Journal of Venous Disorders
- Vol. 18 (3)
Place and role of compression therapy in modern minimally invasive treatment of varicose veins
Chronic venous disease (CVD), which includes varicose veins (VVs) of the lower limbs, is one of the most common and socially significant cardiovascular diseases. Despite the recognition of elastic compression as an essential method of CVD treatment, the benefits and feasibility of its usage during the perioperative period are being reconsidered. This narrative literature review aims to highlight the current evidence of the efficacy of elastic compression in relieving initial and residual vein-specific symptoms, reducing the risk of adverse events and VVs recurrence after surgical treatment. It also provides brief information about the mechanisms of action of compression therapy and discusses compliance issues. Nowadays, the concept of the influence of elastic compression on the diameter of veins and venous outflow velocity has been critically revised. It has been shown that deep veins are more sensitive to external compression, while it is impossible to reduce the caliber of superficial veins under the usual pressure. Extensive evidence indicates the efficacy of compression therapy in relieving venous symptoms, which may persist in 30—40% of patients after surgery. The usage of compression therapy perioperatively helps reduce the rate and severity of such adverse events as pain, bruising, and hyperpigmentation, as well as promotes the resorption of veins after sclerotherapy. However, the optimal mode and duration of compression have not been finally determined. Despite the presence of individual studies, the effect of compression therapy on the progression of CVD and the risk of VVs recurrence has not been proven. The main disadvantage of elastic compression is relatively low compliance, which varies between 26 and 74%. To improve it, both motivational conversations by the doctor and efforts by manufacturers to maintain maximal product quality while giving them optimal properties for comfortable wear are essential. Thus, compression therapy is still an important component of the perioperative treatment of VVs of the lower limb.
- 13 September 2024
- Published by Media Sphere Publishing Group in Journal of Venous Disorders
- Vol. 18 (3)
Place and role of compression therapy in modern minimally invasive treatment of varicose veins
Chronic venous disease (CVD), which includes varicose veins (VVs) of the lower limbs, is one of the most common and socially significant cardiovascular diseases. Despite the recognition of elastic compression as an essential method of CVD treatment, the benefits and feasibility of its usage during the perioperative period are being reconsidered. This narrative literature review aims to highlight the current evidence of the efficacy of elastic compression in relieving initial and residual vein-specific symptoms, reducing the risk of adverse events and VVs recurrence after surgical treatment. It also provides brief information about the mechanisms of action of compression therapy and discusses compliance issues. Nowadays, the concept of the influence of elastic compression on the diameter of veins and venous outflow velocity has been critically revised. It has been shown that deep veins are more sensitive to external compression, while it is impossible to reduce the caliber of superficial veins under the usual pressure. Extensive evidence indicates the efficacy of compression therapy in relieving venous symptoms, which may persist in 30—40% of patients after surgery. The usage of compression therapy perioperatively helps reduce the rate and severity of such adverse events as pain, bruising, and hyperpigmentation, as well as promotes the resorption of veins after sclerotherapy. However, the optimal mode and duration of compression have not been finally determined. Despite the presence of individual studies, the effect of compression therapy on the progression of CVD and the risk of VVs recurrence has not been proven. The main disadvantage of elastic compression is relatively low compliance, which varies between 26 and 74%. To improve it, both motivational conversations by the doctor and efforts by manufacturers to maintain maximal product quality while giving them optimal properties for comfortable wear are essential. Thus, compression therapy is still an important component of the perioperative treatment of VVs of the lower limb.
- 2 April 2024
- Published by ECO-Vector LLC in Bulletin of the Russian Military Medical Academy
- Vol. 26 (1) , 23-33
Pulmonary artery thrombosis prophylaxis and treatment in clinical practice and experiment
The effectiveness of anticoagulant therapy in the prevention and treatment of pulmonary artery thrombosis and the possibility of anti-inflammatory therapy in preventing this complication in clinical practice and experiments were assessed. Data from patients with a new coronavirus infection and those suffering from urgent noninfectious pathology with confirmed pulmonary artery thrombosis were retrospectively analyzed. The outcomes of anticoagulant therapy and anticoagulant therapy combined with glucocorticoid and/or anticytokine drugs were assessed. Histological preparations of the lung vessels of patients were examined. Using an experimental model of rats with induced thrombosis of the posterior vena cava, changes in the pulmonary artery branches were assessed in the main group administered with edible mussel (Mytilus edulis) hydrolyzate and the control group given a physiological solution. No statistically significant relationship was found between the therapeutic, intermediate, and preventive anticoagulant therapy regimens and mortality, changes in lung dynamics, and D-dimer levels in 313 patients with new coronavirus infection. No predominance of any anticoagulant therapy regimen used was found among deceased patients. Thirty-nine patients were treated with glucocorticoid and/or anticytokine drugs in the presence of anticoagulant therapy. No statistically significant relationship in the onset of thrombotic complications was found between the groups receiving therapy with glucocorticoid and anticytokine drugs. No differences were noted in the drug-induced pathomorphosis of the wall of the pulmonary artery branches in the group receiving anticoagulant therapy or in the group receiving a combination of anticoagulant therapy and glucocorticoid and/or anticytokine drugs. Pulmonary artery thrombosis developed in all 19 patients suffering from urgent noninfectious pathology, 11 of whom were under anticoagulant therapy. In 12 of 15 rats in the control group with thrombosis of the posterior vena cava, blood clots were found in the lumen of the pulmonary artery branches. In 14 rats of the main group administered M. edulis hydrolyzate, no blood clots were found in the pulmonary artery branches. Thus, the systemic effects of anticoagulant therapy were offset by the local prothrombotic effects of the vascular wall caused by inflammation. Glucocorticoid and anticytokine drugs did not affect inflammatory changes in the vascular wall and did not prevent pulmonary artery thrombosis. The introduction of M. edulis in the experiment prevented pulmonary artery thrombosis in the presence of posterior vena cava thrombosis, which indicates a promising direction in the search for pathogenetic prevention of this complication.
- 2 April 2024
- Published by ECO-Vector LLC in Bulletin of the Russian Military Medical Academy
- Vol. 26 (1) , 23-33
Pulmonary artery thrombosis prophylaxis and treatment in clinical practice and experiment
The effectiveness of anticoagulant therapy in the prevention and treatment of pulmonary artery thrombosis and the possibility of anti-inflammatory therapy in preventing this complication in clinical practice and experiments were assessed. Data from patients with a new coronavirus infection and those suffering from urgent noninfectious pathology with confirmed pulmonary artery thrombosis were retrospectively analyzed. The outcomes of anticoagulant therapy and anticoagulant therapy combined with glucocorticoid and/or anticytokine drugs were assessed. Histological preparations of the lung vessels of patients were examined. Using an experimental model of rats with induced thrombosis of the posterior vena cava, changes in the pulmonary artery branches were assessed in the main group administered with edible mussel (Mytilus edulis) hydrolyzate and the control group given a physiological solution. No statistically significant relationship was found between the therapeutic, intermediate, and preventive anticoagulant therapy regimens and mortality, changes in lung dynamics, and D-dimer levels in 313 patients with new coronavirus infection. No predominance of any anticoagulant therapy regimen used was found among deceased patients. Thirty-nine patients were treated with glucocorticoid and/or anticytokine drugs in the presence of anticoagulant therapy. No statistically significant relationship in the onset of thrombotic complications was found between the groups receiving therapy with glucocorticoid and anticytokine drugs. No differences were noted in the drug-induced pathomorphosis of the wall of the pulmonary artery branches in the group receiving anticoagulant therapy or in the group receiving a combination of anticoagulant therapy and glucocorticoid and/or anticytokine drugs. Pulmonary artery thrombosis developed in all 19 patients suffering from urgent noninfectious pathology, 11 of whom were under anticoagulant therapy. In 12 of 15 rats in the control group with thrombosis of the posterior vena cava, blood clots were found in the lumen of the pulmonary artery branches. In 14 rats of the main group administered M. edulis hydrolyzate, no blood clots were found in the pulmonary artery branches. Thus, the systemic effects of anticoagulant therapy were offset by the local prothrombotic effects of the vascular wall caused by inflammation. Glucocorticoid and anticytokine drugs did not affect inflammatory changes in the vascular wall and did not prevent pulmonary artery thrombosis. The introduction of M. edulis in the experiment prevented pulmonary artery thrombosis in the presence of posterior vena cava thrombosis, which indicates a promising direction in the search for pathogenetic prevention of this complication.
- 15 December 2023
- Published by PANORAMA Publishing House in Hirurg (Surgeon)
- No. 6,p. 54-66
The evolution of the Caprini score
The article is a narrative review of the literature that addresses the issues of individual risk assessment of hospital-acquired VTE using the Caprini score. It provides modern epidemiological data confirming the high medical and social significance of the problem of hospital venous thrombosis. The questions of the natural evolution of the Caprini score since the publication of the initial version in 1991 are discussed, a comparative analysis of the modifications of 2005, 2010 and 2013 is carried out, and the features of validation studies that have proven the superiority of the classical version of 2005 are discussed. Attention is paid to the problem of integrating the Caprini score into medical documentation with automation of the process of risk assessment and the appointment of preventive measures. The issue of heterogeneity of approaches to dividing patients into risk groups for developing VTE in accordance with the assessed scores is discussed separately; data from modern studies are presented confirming the existence of very high (9–10 points) and extremely high (≥11 points) risk groups that require an individual approach to prevention of thrombotic complications. Summary data are provided on the frequency of registration of VTE in accordance with Caprini scores in patients of various medical profiles based on a meta-analysis of 68 validation studies. The possibility of using patient-oriented questionnaires based on the Caprini score is discussed, which demonstrate high consistency with the original scale, but have not yet been studied in prospective studies. Revised algorithms are proposed to individually assess the risk of VTE using the 2005 vers of the Caprini score and prescribe adequate prophylaxis. It is concluded that the Caprini score still continues to improve and evolve in accordance with general trends in the development of medicine and healthcare, while maintaining the status of the most studied and in demand system for individual assessment of the risk of developing hospital-acquired VTE.
- 15 December 2023
- Published by PANORAMA Publishing House in Hirurg (Surgeon)
- No. 6,p. 54-66
The evolution of the Caprini score
The article is a narrative review of the literature that addresses the issues of individual risk assessment of hospital-acquired VTE using the Caprini score. It provides modern epidemiological data confirming the high medical and social significance of the problem of hospital venous thrombosis. The questions of the natural evolution of the Caprini score since the publication of the initial version in 1991 are discussed, a comparative analysis of the modifications of 2005, 2010 and 2013 is carried out, and the features of validation studies that have proven the superiority of the classical version of 2005 are discussed. Attention is paid to the problem of integrating the Caprini score into medical documentation with automation of the process of risk assessment and the appointment of preventive measures. The issue of heterogeneity of approaches to dividing patients into risk groups for developing VTE in accordance with the assessed scores is discussed separately; data from modern studies are presented confirming the existence of very high (9–10 points) and extremely high (≥11 points) risk groups that require an individual approach to prevention of thrombotic complications. Summary data are provided on the frequency of registration of VTE in accordance with Caprini scores in patients of various medical profiles based on a meta-analysis of 68 validation studies. The possibility of using patient-oriented questionnaires based on the Caprini score is discussed, which demonstrate high consistency with the original scale, but have not yet been studied in prospective studies. Revised algorithms are proposed to individually assess the risk of VTE using the 2005 vers of the Caprini score and prescribe adequate prophylaxis. It is concluded that the Caprini score still continues to improve and evolve in accordance with general trends in the development of medicine and healthcare, while maintaining the status of the most studied and in demand system for individual assessment of the risk of developing hospital-acquired VTE.
- Open Access
- 14 December 2023
- Published by ECO-Vector LLC in HERALD of North-Western State Medical University named after I.I. Mechnikov
- Vol. 15 (3) , 75-84
Pulmonary artery thrombosis. Clinical aspects and the possibility of prognosis
BACKGROUND: Recently, there has been a growing interest to the pulmonary artery thrombosis due to the collected data on pathogenesis of this complication and the awareness about developing diagnostic and therapeutic strategy distinctive from those in pulmonary embolism. AIM: To estimate the pulmonary artery thrombosis clinical presentation, its electrocardiographic and echocardiographic signs and the possibility of applying venous thromboembolism risk assessment scores and diagnostic scoring systems in the cohort of deceased patients with verified pulmonary artery thrombosis. MATERIALS AND METHODS: A retrospective study based on the medical records analysis of two groups of deceased patients has been carried out. The first group included 80 patients with pulmonary artery thrombosis and the second one included 42 patients with pulmonary embolism. All the patients’ diagnoses were confirmed by the results of sectional and histological studies. 61 patient with COVID-19 and 19 non-COVID urgent patients with different pathologies were included in pulmonary artery thrombosis group. All 42 patients in pulmonary embolism group had verified venous thrombosis or heart chambers thrombi. Clinical presentation peculiarities, the electrocardiographic and echocardiographic reports as well as the possibility of application of Caprini, IMPROVE VTE, Padua, Wells and Geneva scoring systems were analyzed. RESULTS: None of the 80 pulmonary artery thrombosis patients had hemoptysis, unexpected dyspnoea, sudden strong cough, chest pain, or syncopea. Electrocardiographic changes indicative of right ventricular strain were found in 52.5% in the pulmonary artery thrombosis group and in 57.1% in the pulmonary embolism group. Inversion of T waves, complete and incomplete right bundle branch block were recorded in 14.6% and in 12.5%, in 36.3% and in 47.5% in the pulmonary artery thrombosis group and in the pulmonary embolism group, respectively, without statistical significance between two groups. Echocardiographic findings of right ventricular overload and/or dysfunction were present in 5 out of 10 patients with pulmonary artery thrombosis and in 5 out of 9 patients with pulmonary embolism. The correlation between Caprini, IMPROVE VTE and Padua scores and the incidence of pulmonary artery thrombosis was as strong as with the incidence of pulmonary embolism. On the contrary, Wells and Geneva clinical prediction scores failed to determine the probability of pulmonary artery thrombosis. CONCLUSIONS: Pulmonary artery thrombosis occurs without obvious clinical manifestations typical for pulmonary embolism. Electrocardiography and echocardiography reveal right ventricular overload in pulmonary artery thrombosis and in pulmonary embolism with equal frequency. Patients with high risk of pulmonary artery thrombosis can be identified by using the Caprini, IMPROVE VTE, Padua Prediction scores.
- 14 December 2023
- Published by ECO-Vector LLC in HERALD of North-Western State Medical University named after I.I. Mechnikov
- Vol. 15 (3) , 75-84
Open AccessPulmonary artery thrombosis. Clinical aspects and the possibility of prognosis
BACKGROUND: Recently, there has been a growing interest to the pulmonary artery thrombosis due to the collected data on pathogenesis of this complication and the awareness about developing diagnostic and therapeutic strategy distinctive from those in pulmonary embolism. AIM: To estimate the pulmonary artery thrombosis clinical presentation, its electrocardiographic and echocardiographic signs and the possibility of applying venous thromboembolism risk assessment scores and diagnostic scoring systems in the cohort of deceased patients with verified pulmonary artery thrombosis. MATERIALS AND METHODS: A retrospective study based on the medical records analysis of two groups of deceased patients has been carried out. The first group included 80 patients with pulmonary artery thrombosis and the second one included 42 patients with pulmonary embolism. All the patients’ diagnoses were confirmed by the results of sectional and histological studies. 61 patient with COVID-19 and 19 non-COVID urgent patients with different pathologies were included in pulmonary artery thrombosis group. All 42 patients in pulmonary embolism group had verified venous thrombosis or heart chambers thrombi. Clinical presentation peculiarities, the electrocardiographic and echocardiographic reports as well as the possibility of application of Caprini, IMPROVE VTE, Padua, Wells and Geneva scoring systems were analyzed. RESULTS: None of the 80 pulmonary artery thrombosis patients had hemoptysis, unexpected dyspnoea, sudden strong cough, chest pain, or syncopea. Electrocardiographic changes indicative of right ventricular strain were found in 52.5% in the pulmonary artery thrombosis group and in 57.1% in the pulmonary embolism group. Inversion of T waves, complete and incomplete right bundle branch block were recorded in 14.6% and in 12.5%, in 36.3% and in 47.5% in the pulmonary artery thrombosis group and in the pulmonary embolism group, respectively, without statistical significance between two groups. Echocardiographic findings of right ventricular overload and/or dysfunction were present in 5 out of 10 patients with pulmonary artery thrombosis and in 5 out of 9 patients with pulmonary embolism. The correlation between Caprini, IMPROVE VTE and Padua scores and the incidence of pulmonary artery thrombosis was as strong as with the incidence of pulmonary embolism. On the contrary, Wells and Geneva clinical prediction scores failed to determine the probability of pulmonary artery thrombosis. CONCLUSIONS: Pulmonary artery thrombosis occurs without obvious clinical manifestations typical for pulmonary embolism. Electrocardiography and echocardiography reveal right ventricular overload in pulmonary artery thrombosis and in pulmonary embolism with equal frequency. Patients with high risk of pulmonary artery thrombosis can be identified by using the Caprini, IMPROVE VTE, Padua Prediction scores.
- 29 August 2023
- Published by PANORAMA Publishing House in Hirurg (Surgeon)
- No. 4,p. 17-26
Minimally invasive surgical technologies in the treatment of anal fistulas (literature review)
- 29 August 2023
- Published by PANORAMA Publishing House in Hirurg (Surgeon)
- No. 4,p. 17-26
Minimally invasive surgical technologies in the treatment of anal fistulas (literature review)
- 23 June 2023
- Published by PANORAMA Publishing House in Hirurg (Surgeon)
- No. 3,p. 20-33
Minimally invasive laser technologies in the surgical treatment of hemorrhoidal disease: problems and prospects (literature review)
- 23 June 2023
- Published by PANORAMA Publishing House in Hirurg (Surgeon)
- No. 3,p. 20-33
Minimally invasive laser technologies in the surgical treatment of hemorrhoidal disease: problems and prospects (literature review)
- 12 December 2022
- Published by PANORAMA Publishing House in Hirurg (Surgeon)
- No. 6,p. 54-63
Adherence to the use of the caprini score among Russian specialists: results of an electronic survey
The aim of the study was to assess the adherence of Russian doctors to the use of the Caprini risk assessment score for venous thromboembolism complications in real clinical practice. On the basis of the Google Forms platform, an electronic questionnaire was created, with an invitation to complete it sent out by e-mail and through social networks of the educational project «School of Thrombosis». The survey was conducted from October 20 to October 30, 2021. The answers were received from 270 respondents, of which 260 questionnaires from specialists working in Russia were included in the analysis. Among the doctors, specialists in vascular surgery, including phlebology, and general surgery from private clinics and city clinical hospitals prevailed. Up to 90 % of the Russian doctors of various medical specialties are aware of the Caprini scale, up to 77 % actively use it in clinical practice, up to 74 % of the specialists use the score results to make decisions on the tactics of primary prevention of venous thromboembolism complications, and up to 28 % of the respondents interact with the scale integrated into medical records in paper or electronic format. Most respondents noted the availability of modern means of pharmacological prevention, in particular, LMWH and DOAC, in their medical institutions. As for mechanical prophylaxis, elastic bandages and compression stockings were almost equally available, but methods of actively accelerating blood flow could be afforded by no more than 15 % of the respondents. Conclusions: most of the Russian doctors surveyed note a high adherence to the use of the Caprini scale to assess the risk of venous thromboembolic complications in real clinical practice.
- 12 December 2022
- Published by PANORAMA Publishing House in Hirurg (Surgeon)
- No. 6,p. 54-63
Adherence to the use of the caprini score among Russian specialists: results of an electronic survey
The aim of the study was to assess the adherence of Russian doctors to the use of the Caprini risk assessment score for venous thromboembolism complications in real clinical practice. On the basis of the Google Forms platform, an electronic questionnaire was created, with an invitation to complete it sent out by e-mail and through social networks of the educational project «School of Thrombosis». The survey was conducted from October 20 to October 30, 2021. The answers were received from 270 respondents, of which 260 questionnaires from specialists working in Russia were included in the analysis. Among the doctors, specialists in vascular surgery, including phlebology, and general surgery from private clinics and city clinical hospitals prevailed. Up to 90 % of the Russian doctors of various medical specialties are aware of the Caprini scale, up to 77 % actively use it in clinical practice, up to 74 % of the specialists use the score results to make decisions on the tactics of primary prevention of venous thromboembolism complications, and up to 28 % of the respondents interact with the scale integrated into medical records in paper or electronic format. Most respondents noted the availability of modern means of pharmacological prevention, in particular, LMWH and DOAC, in their medical institutions. As for mechanical prophylaxis, elastic bandages and compression stockings were almost equally available, but methods of actively accelerating blood flow could be afforded by no more than 15 % of the respondents. Conclusions: most of the Russian doctors surveyed note a high adherence to the use of the Caprini scale to assess the risk of venous thromboembolic complications in real clinical practice.
- Open Access
- 19 November 2022
- Published by Remedium, Ltd. in Ambulatornaya khirurgiya = Ambulatory Surgery (Russia)
- Vol. 19 (2) , 62-71
Current state of the problem of risk assessment and prevention of venous thromboembolic complications after thermal obliteration of superficial veins
Venous thromboembolic complications (VTEO) after modern minimally invasive superficial vein interventions are an infrequent but very dramatic event. This article presents a review of the literature, covering the issues of prevalence, prognosis and pharmacological prevention of VTEO. The performed studies demonstrate that the incidence of symptomatic thrombotic complications after endovenous thermal obliteration does not exceed 0,5%, but taking into account asymptomatic thermally induced thromboses and subclinical occlusions of the muscular veins of the lower leg, this figure can exceed 10%. There is a high heterogeneity of the data, possibly due to differences in the individual risk of VTEO. The most validated tool for assessing the latter is the Caprini Scale, which has not been sufficiently studied in the surgical treatment of varicose veins. The administration of prophylactic doses of anticoagulants after thermal obliteration of saphenous veins is widely used in routine clinical practice, despite the lack of convincing evidence for the appropriateness of this approach. In recent years, the use of direct oral anticoagulants against the official instruction (off-label) has gained great popularity as an alternative to heparin. The largest evidence base has accumulated for the use of rivaroxaban 10 mg, which is associated with high efficacy and safety. Based on completed clinical trials, it is not possible to formulate unequivocal recommendations for prophylactic anticoagulant doses after thermal obliteration of superficial veins at this time. Additional studies are required to identify patients with an individually increased risk of thrombosis in whom prophylactic doses of anticoagulants may be of maximum benefit.
- 19 November 2022
- Published by Remedium, Ltd. in Ambulatornaya khirurgiya = Ambulatory Surgery (Russia)
- Vol. 19 (2) , 62-71
Open AccessCurrent state of the problem of risk assessment and prevention of venous thromboembolic complications after thermal obliteration of superficial veins
Venous thromboembolic complications (VTEO) after modern minimally invasive superficial vein interventions are an infrequent but very dramatic event. This article presents a review of the literature, covering the issues of prevalence, prognosis and pharmacological prevention of VTEO. The performed studies demonstrate that the incidence of symptomatic thrombotic complications after endovenous thermal obliteration does not exceed 0,5%, but taking into account asymptomatic thermally induced thromboses and subclinical occlusions of the muscular veins of the lower leg, this figure can exceed 10%. There is a high heterogeneity of the data, possibly due to differences in the individual risk of VTEO. The most validated tool for assessing the latter is the Caprini Scale, which has not been sufficiently studied in the surgical treatment of varicose veins. The administration of prophylactic doses of anticoagulants after thermal obliteration of saphenous veins is widely used in routine clinical practice, despite the lack of convincing evidence for the appropriateness of this approach. In recent years, the use of direct oral anticoagulants against the official instruction (off-label) has gained great popularity as an alternative to heparin. The largest evidence base has accumulated for the use of rivaroxaban 10 mg, which is associated with high efficacy and safety. Based on completed clinical trials, it is not possible to formulate unequivocal recommendations for prophylactic anticoagulant doses after thermal obliteration of superficial veins at this time. Additional studies are required to identify patients with an individually increased risk of thrombosis in whom prophylactic doses of anticoagulants may be of maximum benefit.